30
Site Performance Compounding: Finding the Right Formula for Planning to Prevent Poor Patient Enrollment at Investigative Sites Dan McDonald DAC Patient Recruitment Services August 12, 2014 1

Clinical Trials: Preventing Poor Patient Enrollment

Embed Size (px)

DESCRIPTION

For years, compounding pharmacists have specialized in customizing medications when mass-produced products just won’t do. This personalized approach to treatment requires therapeutic understanding, deep and relevant experience, and the flexibility to adapt clinical formulas for success. Likewise, as clinical trial protocols become more complex and targeted, the industry is discovering that cookie-cutter strategies for finding and supporting investigative sites with patient recruitment are insufficient. Topics Include: Leveraging big data to identify sites with the highest probability of enrollment success Applying a recruitment mindset to the site feasibility questionnaire and interview process Developing and nurturing strong relationships with investigators and study coordinators to improve enthusiasm and dedication to enrollment excellence FOR MORE INFORMATION, VISIT WWW.IMPERIALCRS.COM

Citation preview

Page 1: Clinical Trials: Preventing Poor Patient Enrollment

Site Performance Compounding: Finding the

Right Formula for Planning to Prevent Poor

Patient Enrollment at Investigative Sites

Dan McDonald

DAC Patient Recruitment Services

August 12, 2014

1

Page 2: Clinical Trials: Preventing Poor Patient Enrollment

Question & Answer

• We will be using the chat feature for question and answer.

• During the presentation, please type in your question in the chat box at that bottom of the control panel on the right hand side of the screen.

• At the conclusion of the presentation, Dan will answer your questions.

2

Page 3: Clinical Trials: Preventing Poor Patient Enrollment

3

Speaker Introduction

Dan works from DAC’s Boston office identifying income opportunities, building strategic

partnerships, and managing contract negotiations. He re-joined the team in 2013, having previously served in the area of strategic and business development under DAC’s former brand moniker, D. Anderson & Company, from 2006 to 2007. Dan has authored many articles for industry publications, is a popular presenter at industry conferences, and has conducted numerous workshops on patient recruitment for clinical trials.

Page 4: Clinical Trials: Preventing Poor Patient Enrollment

4

Setting the

Stage

Page 5: Clinical Trials: Preventing Poor Patient Enrollment

5

Page 6: Clinical Trials: Preventing Poor Patient Enrollment

6

Page 7: Clinical Trials: Preventing Poor Patient Enrollment

When to

Plan?

Answer – At Inception

7

Page 8: Clinical Trials: Preventing Poor Patient Enrollment

What can go wrong, very well may without proper planning (which includes contingencies)!!!

Unreasonable and under-vetted protocol design

Incomplete and/or inaccurate feasibility data

Patient pools dry up after study start

Poor communication channels with sites

Cultural differences and communication gaps

Lack of customized patient recruitment plan;

Lack of risk mitigation strategies

Scope and budget creep

Unmotivated or angry investigators

Delays, delays, delays

Sure, go ahead, leave it to chance!

Lions, Tigers & Bears ─ Oh My!

Page 9: Clinical Trials: Preventing Poor Patient Enrollment

Protocols are designed to satisfy FDA scientific

requirements and advance science:

What about the reality of conducting the

study?

Does the target patient population exist?

Invite ―operators‖ to evaluate the protocol

Leverage ―big data‖ when available.

Who will be involved in the decision to

participate? Caregiver support required?

Protocol Design

9

Page 10: Clinical Trials: Preventing Poor Patient Enrollment

66% of sites only conduct one study. Why?

What questions should we ask?

Openness; flexibility; attitude:

A Recruitment Mindset for the Feasibility Process

Responsiveness

Openness to Training

Willing to Implement Recruitment Procedures

Acceptance of Outside Support

Page 11: Clinical Trials: Preventing Poor Patient Enrollment

A Recruitment Mindset for the Feasibility Process

• Ensure mix of KOLs with lesser-known, competent, enthusiastic PIs

• Consider location in a country:

• PI’s in Tier 2 and 3 cities often perform better

• Capture metrics on past performance for similar studies

• Ensure no participation in competing studies

• Determine catchment area around site and referral patterns

• Consider accessibility and convenience factors for subjects

Page 12: Clinical Trials: Preventing Poor Patient Enrollment

Data-Driven Approaches Impactful Highest % Areas Are Red or Hot; Lowest Are Blue or Cold

12

Rank the best

geographic

areas based on

prevalence,

Patient

Definition

Raw

Patient Count (Insured, & Medicare)

Projected

Patient Count (All Patients, Inc.

Uninsured)

Investigator

Count (w/ Matching

Patients

Physician Count (w/ Matching Patients)

Cardio-

pulmonary

Bypass

4,498 62,789 369 1,564

Page 13: Clinical Trials: Preventing Poor Patient Enrollment

Also…..

If a 3+ month lag occurs, re-

evaluate competitive

market and conduct a 2nd,

small scale feasibility with

previously selected sites.

Minimize lag time

between site feasibility,

investigator meeting and

study initiation.

Page 14: Clinical Trials: Preventing Poor Patient Enrollment

14

Enroll within 90+ days <10% chance of success

Enroll within 60 days 50% chance of success

Enroll within 30 days 90%+ chance of success

Typically, Enrollment Timelines Drive Success

Page 15: Clinical Trials: Preventing Poor Patient Enrollment

Answer – A plan

15

What to Plan?

Page 16: Clinical Trials: Preventing Poor Patient Enrollment

Critical to develop expertise with regards to the recruitment landscape

Consider developing a proactive recruitment plan for each site

The ways in which patients can be engaged at the investigative site

Which types of initiatives prove successful when supporting sites

Typical utilization rates for the various recruitment strategies by sites

Which recruitment materials require EC approval & approval timelines

Understand how patients first learn about clinical trials

Identify common stakeholders in the consent decision process

Engage CRAs, as they provide a critical link with the investigative site

Involve local expertise and networks to cast a wider net

Patient Recruitment Planning

Plan upfront to utilize external

recruitment and/or retention support whether implemented or not.

Page 17: Clinical Trials: Preventing Poor Patient Enrollment

Plan a Plan

17

“Success is when everything that goes wrong, fits in your plan.” ― Gary Rudz.”

Page 18: Clinical Trials: Preventing Poor Patient Enrollment

Establish a line item for recruitment and retention in each study budget

Recruitment cost per patient: $1,500–$10,000+ (depending on factors)

Consider allocating 5% of site per patient grants for retention.

90% of sites have no formal plan/funds to address retention.

Increase allocation based on TA or long-term safety study.

Common Contingencies for Slow Enrollment

Hire new CRO

Addition of sites – avg. $20–$30K/site in the U.S.

Protocol amendments – avg. $1M/protocol

Extend timeline – avg.

Out of Pocket Costs: $100-150K (day)

Opportunity Costs: $1M (day)

Effective contingency planning requires proper support.

Contingency Planning

18

Page 19: Clinical Trials: Preventing Poor Patient Enrollment

Answer – Listen

19

How to Engage

Sites in Your

Plan

Page 20: Clinical Trials: Preventing Poor Patient Enrollment

Establish forums that allow CRCs to have a ―voice.‖

Study-specific trainings

Face-to-face

Web conference

Advisory committee

CRCs are their own best advocates.

Engaging CRCs has a proven direct impact on

lagging enrollment.

20

CRCs are the Backbone of Sites – Give Them a Voice!

Page 21: Clinical Trials: Preventing Poor Patient Enrollment

Consider Factors for Strong Investigator Relations

Proactively address investigator concerns with protocol.

Consider need for local representation.

CTAs should be milestone driven.

Ensure fair allocation of site grant to PI.

Be sensitive to regional compensation differences.

In-person sponsor visits have many benefits.

Consider critical site support personal availability.

Determine availability of onsite CRC or through contract.

Be wary of investigator leveraging and strong-arming.

Set aside funds for investigator recognition.

Consider mid-study rejuvenation meetings.

Have backup sites contracted, approved and ready.

It’s 2014– Investigators the world over can easily communicate with each other and often do. Avoid unfair and unjustified compensation differences

Page 22: Clinical Trials: Preventing Poor Patient Enrollment

Answer – Planning!

22

Planning vs….

That Other

Thing

Page 23: Clinical Trials: Preventing Poor Patient Enrollment

After six months, enrollment is lagging.

Decision is made to amend the

protocol and replace 30 sites.

Amended protocol cost estimate = $1M

Site replacement cost = $900K

Total amended project cost — $11.9M

(19% budget increase)

Rescue Costing Scenario

23

Page 24: Clinical Trials: Preventing Poor Patient Enrollment

After six months, enrollment is lagging.

Decision made to add a centralized

recruitment campaign:

Start-up timeline (2–3 months)

Costs of delays for program

implementation (~$250K)

Recruitment campaign — $1M

Total amended project cost — $11.3M

(13% budget increase)

Rescue Costing Scenario

24

Page 25: Clinical Trials: Preventing Poor Patient Enrollment

Implement a proactive

recruitment program

Recruitment campaign — $500K

Total amended project cost —

$10.5M (5% budget increase)

Proactive Costing Scenario

25

Page 26: Clinical Trials: Preventing Poor Patient Enrollment

Rescue

Total amended project cost — $11.9M

(19% budget increase)

Total amended project cost — $11.3M

(13% budget increase)

Proactive

Total amended project cost — $10.5M

(5% budget increase)

Cost savings with PROACTIVE planning

160%–280%

Proactive vs. Rescue Cost Savings

26

Page 27: Clinical Trials: Preventing Poor Patient Enrollment

Consider expanding your protocol review team.

Apply a recruitment mindset to the feasibility process.

Sites are a critical partner in the success of your study – treat them like it.

If nothing else, develop a proactive recruitment and/or retention plan.

Establish recruitment/retention line items in your study budgets.

Follow-through

And, enjoy study success!!!

In Summary….

27

Page 28: Clinical Trials: Preventing Poor Patient Enrollment

Dan McDonald Business Development

617-840-5405 [email protected]

28

Page 29: Clinical Trials: Preventing Poor Patient Enrollment

Rescue Training Can Jumpstart Enrollment…..

78 Sites Attended August Meeting or Webinar

42 Sites have Pre-Screened 82 Patients

28 Sites Consented 38 Patients

19 Sites have Randomized 24 Patients

29

Page 30: Clinical Trials: Preventing Poor Patient Enrollment

Expected Randomization as of December 2, 2013 = 43

Actual Randomization as of December 2, 2013 = 65 – A 51% increase over expected!!

Investment - $6,175 vs. rescue = 300% cost savings and enrollment is ahead of schedule!

30

Study Enrollment

…But, Proactive Training Can Ensure that Projected

Enrollment Timelines are Achieved or Exceeded